Business
Macy's operates Macy's, Bloomingdale's and Bluemercury stores and digital channels.
Macy's: Revenue declined 2.4% to $21.764B from $22.293B. Net income grew 10.3% to $642M from $582M. Free cash flow grew 39.1% to $1.057B from $760M. Operating margin expanded 65 bps to 4.73%. Macy's's annual comparison also shows stock compensation grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 2.4%Watch
- Profitability — Net income grew 10.3% to $642M from $582MOK
- Cash flow — Free cash flow grew 39.1% to $1.057B from $760MOK
- Margins — Operating margin expanded 65 bps to 4.73%OK
- Accounting — No overriding statistical warningNote
- Insiders — 0 purchases and 26 salesWatch
Where the revenue comes from
Fiscal 2025, as Macy's, Inc. reports it. History and quarterly detail are in the app.
- Women’s Accessories, Shoes, Cosmetics and Fragrances$9.1B
- Women’s Apparel$4.8B
- Men’s and Kids’$4.7B
- Home/Other$3.2B
Leadership changes
From Macy's, Inc.'s own filings, the day they're filed.
- Tracey Zhen · Directors · departureeff. 2026-03-25
- Douglas W. Sesler · Directors · departureeff. 2026-03-25
- Thomas J. Edwards Jr · appointmenteff. 2025-06-22
Latest filings
- 10-Q · Quarterly report2026-06-04
- 8-K · Company announcement2026-06-03
- 8-K · Company announcement2026-05-18
- DEF 14A · Annual proxy (pay & governance)2026-03-31
- 10-K · Annual report2026-03-27
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Macy's, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.